Linked Data API

Show Search Form

Search Results

518800
star this property registered interest false remove filter
star this property date less than 2016-05-18more like thismore than 2016-05-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Prime Minister: Ministerial Policy Advisers more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what action they are taking to ensure that NICE guidance is followed in the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL94 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2016-05-26more like thismore than 2016-05-26
star this property answer text <p>The National Institute for Health and Care Excellence has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection under the interventional procedure programme. This programme makes recommendations about the safety of the procedures and how well they work. However the guidance does not constitute a direction to National Health Service trusts to provide the interventions. Decisions about whether to provide a treatment are taken locally.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN HL97 more like this
star this property question first answered
less than 2016-05-26T16:29:01.177Zmore like thismore than 2016-05-26T16:29:01.177Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
76618
star this property registered interest false remove filter
star this property date less than 2014-07-09more like thismore than 2014-07-09
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Neurofibromatosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have to develop a national service framework for neurofibromatosis Type 1 sufferers. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL960 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-07-14more like thismore than 2014-07-14
star this property answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p>
star this property answering member printed Earl Howe more like this
star this property grouped question UIN
HL961 more like this
HL962 more like this
star this property question first answered
less than 2014-07-14T16:18:37.8359721Zmore like thismore than 2014-07-14T16:18:37.8359721Z
star this property answering member
2000
star this property label Biography information for Earl Howe more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
76619
star this property registered interest false remove filter
star this property date less than 2014-07-09more like thismore than 2014-07-09
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Neurofibromatosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how they will ensure a co-ordinated response at local level for neurofibromatosis Type 1 sufferers. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL961 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-07-14more like thismore than 2014-07-14
star this property answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p>
star this property answering member printed Earl Howe more like this
star this property grouped question UIN
HL960 more like this
HL962 more like this
star this property question first answered
less than 2014-07-14T16:18:38.4851111Zmore like thismore than 2014-07-14T16:18:38.4851111Z
star this property answering member
2000
star this property label Biography information for Earl Howe more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
76620
star this property registered interest false remove filter
star this property date less than 2014-07-09more like thismore than 2014-07-09
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Neurofibromatosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what is the scale of neurofibromatosis Type 1 in the United Kingdom. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL962 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-07-14more like thismore than 2014-07-14
star this property answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p>
star this property answering member printed Earl Howe more like this
star this property grouped question UIN
HL960 more like this
HL961 more like this
star this property question first answered
less than 2014-07-14T16:18:38.5632682Zmore like thismore than 2014-07-14T16:18:38.5632682Z
star this property answering member
2000
star this property label Biography information for Earl Howe more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
518801
star this property registered interest false remove filter
star this property date less than 2016-05-18more like thismore than 2016-05-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Prime Minister: Ministerial Policy Advisers more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of the outcome and cost effectiveness of the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL95 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2016-05-26more like thismore than 2016-05-26
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> is not collected centrally.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN HL96 more like this
star this property question first answered
less than 2016-05-26T16:25:27.557Zmore like thismore than 2016-05-26T16:25:27.557Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
518802
star this property registered interest false remove filter
star this property date less than 2016-05-18more like thismore than 2016-05-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Burial and Cremation more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of the rate of uptake by the NHS of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL96 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2016-05-26more like thismore than 2016-05-26
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> is not collected centrally.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN HL95 more like this
star this property question first answered
less than 2016-05-26T16:25:27.73Zmore like thismore than 2016-05-26T16:25:27.73Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
518803
star this property registered interest false remove filter
star this property date less than 2016-05-18more like thismore than 2016-05-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Prime Minister: Ministerial Policy Advisers more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what action they are taking to ensure that NICE guidance is followed in the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL97 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2016-05-26more like thismore than 2016-05-26
star this property answer text <p>The National Institute for Health and Care Excellence has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection under the interventional procedure programme. This programme makes recommendations about the safety of the procedures and how well they work. However the guidance does not constitute a direction to National Health Service trusts to provide the interventions. Decisions about whether to provide a treatment are taken locally.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN HL94 more like this
star this property question first answered
less than 2016-05-26T16:29:01.247Zmore like thismore than 2016-05-26T16:29:01.247Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
347224
star this property registered interest false remove filter
star this property date less than 2015-05-28more like thismore than 2015-05-28
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
unstar this property hansard heading Health Services: Staffordshire more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what action they are taking to ensure the viability of comprehensive patient services in the Staffordshire local health economy. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL88 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2015-06-09more like thismore than 2015-06-09
star this property answer text <p>NHS England has identified the Staffordshire clinical commissioning groups (CCGs) as high risk, and as such is monitoring their performance on a monthly basis with a full quarterly review of finance and performance. NHS England increases the intensity of performance reviews where there are significant shortfalls. This includes weekly meetings with CCGs where appropriate.</p><p> </p><p> </p><p> </p><p>Collaborative working relationships are a critical factor in securing sustainable services in any local health economy. The Commissioning Congress has been set up in Staffordshire to bring together both CCGs and local authority commissioners. The Congress will lead the Transformation Strategy which will drive the service redesign of the Staffordshire Health and Social Care economy to secure financial and clinically sustainable services in the long term. The Congress will engage with local providers in developing these plans to ensure that there is a single five-year plan for the local health economy. This work will lead to a full public consultation on those services during the autumn of 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The Congress brings together the combined skills, knowledge and expertise of commissioners to work the provider sector on defining the range, scale and scope of services changes to ensure Staffordshire is both clinically and financially sustainable in the long term.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL90 more like this
HL91 more like this
HL92 more like this
HL93 more like this
star this property question first answered
less than 2015-06-09T12:42:46.753Zmore like thismore than 2015-06-09T12:42:46.753Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
752445
star this property registered interest false remove filter
star this property date less than 2017-07-17more like thismore than 2017-07-17
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text Her Majesty's Government how many contracts for Specialist Audiology Services used by children, and commissioned directly by NHS England, are due to be renegotiated in the financial year 2017-18. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL891 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2017-07-20
star this property answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p>
star this property answering member printed Baroness Chisholm of Owlpen more like this
star this property grouped question UIN
HL887 more like this
HL889 more like this
HL890 more like this
HL979 more like this
star this property question first answered
less than 2017-07-20T14:50:43.93Zmore like thismore than 2017-07-20T14:50:43.93Z
star this property answering member
4330
star this property label Biography information for Baroness Chisholm of Owlpen more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter
753291
star this property registered interest false remove filter
star this property date less than 2017-07-18more like thismore than 2017-07-18
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health remove filter
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text Her Majesty's Government whether they intend to ensure that Clinical Commissioning Groups are notified when a paediatric audiology service does not meet the standards for Improving Quality in Physiological Services accreditation following an assessment visit. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL979 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2017-07-20
star this property answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p>
star this property answering member printed Baroness Chisholm of Owlpen more like this
star this property grouped question UIN
HL887 more like this
HL889 more like this
HL890 more like this
HL891 more like this
star this property question first answered
less than 2017-07-20T14:50:44.047Zmore like thismore than 2017-07-20T14:50:44.047Z
star this property answering member
4330
star this property label Biography information for Baroness Chisholm of Owlpen more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath remove filter